MedTrace Logo

Haemostasis and Tranexamic Acid in Caesarean Delivery

NCT03742947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-05-14

No results posted yet for this study

Summary

The aim of the study is to evaluate haemostasis and fibrinolysis in peripartum of caesarean delivery and the effect of tranexamic acid (TXA) given in prevention of post-partum haemorrhage (PPH).

Conditions

  • Postpartum Hemorrhage
  • Hyperfibrinolysis

Interventions

DIAGNOSTIC_TEST

peripartum haemostasis

Three blood samples of 20 ml each at T0 after the anaesthesia for the caesarean section and before the administration of the product (TXA or placebo), T15 fifteen minutes after the administration of the product and T120, 2 hours after the administration of the product.

Sponsors & Collaborators

  • Bordeaux Association for Training and Research in Obstetric Gynecology

    collaborator UNKNOWN

  • Association of Anesthesiologists and Intensivists of Vascular Surgery and Transplantation

    collaborator UNKNOWN

  • University Hospital, Bordeaux

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2020-01-17
Completion
2020-01-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03742947 on ClinicalTrials.gov